Who Owns MOONLAKE IMMUNOTHERAPEUTICS (MLTX)? -- Institutional Holders (2026-06-30)
187 institutions reported holding $1.47B of MOONLAKE IMMUNOTHERAPEUTICS (MLTX) in SEC 13F filings for 2026-06-30. Largest institutional holders: BVF INC/IL ($311.5M), Deep Track Capital, LP ($136.3M), T. Rowe Price Investment Management, Inc. ($83.3M), D. E. Shaw & Co., Inc. ($65.5M), Cormorant Asset Management, LP ($62.4M). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|
| 1 | BVF INC/IL | $311.5M | 16.0M | Hold |
| 2 | Deep Track Capital, LP | $136.3M | 7.0M | Added |
| 3 | T. Rowe Price Investment Management, Inc. | $83.3M | 4.3M | New |
| 4 | D. E. Shaw & Co., Inc. | $65.5M | 3.4M | Added |
| 5 | Cormorant Asset Management, LP | $62.4M | 3.2M | Trimmed |
| 6 | Jupiter Topco LLC | $60.1M | 3.1M | New |
| 7 | Logos Global Management LP | $52.1M | 2.7M | Added |
| 8 | Weiss Asset Management LP | $50.3M | 2.6M | Added |
| 9 | CITADEL ADVISORS LLC | $47.9M | 2.5M | Added |
| 10 | TWO SIGMA INVESTMENTS, LP | $33.4M | 1.7M | Added |
| 11 | MPM BIOIMPACT LLC | $31.3M | 1.6M | Trimmed |
| 12 | JPMORGAN CHASE & CO | $27.6M | 1.4M | Added |
| 13 | Vivo Capital, LLC | $27.3M | 1.4M | Added |
| 14 | JANE STREET GROUP, LLC | $22.8M | 1.2M | Added |
| 15 | Point72 Asset Management, L.P. | $22.6M | 1.2M | Trimmed |
| 16 | BlackRock, Inc. | $21.3M | 1.1M | Added |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | $20.3M | 1.0M | Trimmed |
| 18 | Balyasny Asset Management L.P. | $17.8M | 912,715 | Trimmed |
| 19 | GREAT POINT PARTNERS LLC | $16.7M | 855,813 | Added |
| 20 | Candriam S.C.A. | $15.0M | 769,766 | Trimmed |
| 21 | BANK OF AMERICA CORP /DE/ | $14.6M | 751,897 | Added |
| 22 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $14.6M | 750,777 | Added |
| 23 | Trails Edge Capital Partners, LP | $14.6M | 750,000 | New |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.0M | 719,942 | Trimmed |
| 25 | HRT FINANCIAL LP | $13.2M | 679,244 | Added |
Source: SEC Form 13F filings · as of 2026-06-30